Early research (Phase 1)Study completedNCT04316689What this trial is testingFirst-in-human Study of S-588210 (S-488210+S-488211)Who this might be right forLung CancerHead and Neck CancerBladder Cancer+2 more Shionogi 10
Very early researchStudy completedNCT01722149What this trial is testingRe-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma University of Zurich 4
Testing effectiveness (Phase 2)Study completedNCT05041062What this trial is testingImmunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal MesotheliomaWho this might be right forMesotheliomaPeritoneal Mesothelioma University of Chicago 2
Not applicableEnded earlyNCT01271959What this trial is testingChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyWho this might be right forSolid Organ Tumors Precision Therapeutics 167
Not applicableStudy completedNCT02519049What this trial is testing11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)Who this might be right forMesothelioma, Malignant Istituto Clinico Humanitas 30
Testing effectiveness (Phase 2)Study completedNCT00061477What this trial is testingPemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaWho this might be right forMesothelioma Eli Lilly and Company 48
Testing effectiveness (Phase 2)Study completedNCT00227630What this trial is testingPemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)Looking for participantsNCT06477419What this trial is testingSacituzumab Govitecan in People With MesotheliomaWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma; Pleura Memorial Sloan Kettering Cancer Center 33
Not applicableUnknownNCT06031636What this trial is testingOncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma, Advanced Tianjin Medical University Second Hospital 15
Large-scale testing (Phase 3)Study completedNCT02784171What this trial is testingPembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMesothelioma Canadian Cancer Trials Group 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT04300244What this trial is testingNivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant MesotheliomaWho this might be right forCancerCancer, LungCancer of Lung+4 more Åslaug Helland 118
Early research (Phase 1)Ended earlyNCT02838745What this trial is testingStudy of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPMWho this might be right forMesothelioma Baylor College of Medicine 7
Testing effectiveness (Phase 2)UnknownNCT01281800What this trial is testingCisplatin With Alimta or Gemcitabine in Long Infusion for MesotheliomaWho this might be right forMesothelioma Institute of Oncology Ljubljana 72
Testing effectiveness (Phase 2)Study completedNCT02049060What this trial is testingStudy of the Combination of Tivantinib Plus Pemetrexed and CarboplatinWho this might be right forMalignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung Armando Santoro, MD 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790706What this trial is testingIMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE CancersWho this might be right forPeritoneal MesotheliomaGestational Trophoblastic TumorAnaplastic Thyroid Carcinomas+3 more Hospices Civils de Lyon 27
Testing effectiveness (Phase 2)Study completedNCT01486368What this trial is testingA Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374What this trial is testingRandomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaWho this might be right forUnresectable Pleural or Peritoneal Malignant Mesothelioma MedImmune LLC 571
Large-scale testing (Phase 3)Study completedNCT00128102What this trial is testingSuberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)Who this might be right forMesotheliomaLung Cancer Merck Sharp & Dohme LLC 661
Testing effectiveness (Phase 2)Ended earlyNCT01870609What this trial is testingPlacebo Controlled Study of VS-6063 in Subjects With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Verastem, Inc. 344
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241